Biogen (NASDAQ:BIIB – Get Free Report) and Poseida Therapeutics (NASDAQ:PSTX – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Profitability This table compares Biogen and Poseida Therapeutics’ net […]
Biogen Inc. (NASDAQ:BIIB – Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 3,480,000 shares, a growth of 10.5% from the April 30th total of 3,150,000 shares. Based on an average daily volume of 1,220,000 shares, the […]
Carmignac Gestion increased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 16.9% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 361,395 shares of the biotechnology company’s stock after acquiring an additional 52,295 shares during the period. Biogen makes up approximately 1.6% of […]
Rhenman & Partners Asset Management AB raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,672 shares of the biotechnology company’s stock after buying an additional 2,172 shares during […]
Rhenman & Partners Asset Management AB raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 58,672 shares of the biotechnology company’s stock after buying an additional 2,172 shares during […]